Evolent Health Inc
Statements
Cash Flow
Evolent Health Inc (EVH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -10 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.9 | -22 | -35 | -9.9 | 11 | 9.9 | -25 | 6.7 | 22 | -25 | -26 | -14 | -17 | 13 | -21 | 38 | -20 | -13 | -48 | -24 | 45 | 67 | -57 | 14 | -3.5 | 36 | -8.0 | 0.7 | 61 | 89 | 4.9 | 21 | 19 | -26 | 4.6 | -30 | 16 | 49 | -1.0 | -10 | 53 | |
| 3.7 | 6.5 | 6.6 | 6.9 | 7.7 | 11 | 9.5 | 10 | 10 | 15 | 14 | 15 | 15 | 16 | 22 | 20 | 15 | 15 | 15 | 20 | 15 | 15 | 15 | 15 | 19 | 20 | 32 | 32 | 32 | 30 | 30 | 31 | 30 | 30 | 26 | 23 | 24 | -45 | 22 | 43 | 44 | |
| 4.8 | 8.7 | 5.1 | 5.4 | 5.7 | 4.3 | 3.8 | 4.7 | 4.0 | 5.0 | 4.5 | 4.8 | 5.8 | 0.6 | 3.5 | 3.7 | 3.2 | 4.2 | 3.7 | 3.7 | 4.4 | 5.0 | 5.3 | 7.0 | 7.0 | 15 | 11 | 9.0 | 10 | 11 | 19 | 13 | 14 | -6.1 | 11 | 12 | 15 | -2.4 | 11 | 26 | 49 | |
| 5.2 | 4.7 | 6.2 | 5.1 | 4.1 | 0.5 | 3.7 | 4.4 | 5.7 | 4.9 | 5.0 | 8.1 | -2.0 | 177 | 54 | 193 | 26 | 4.4 | 17 | -75 | -28 | 18 | 10 | 7.5 | -42 | -2.5 | -50 | -1.2 | 13 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 15 | -7.5 | -25 | -2.5 | 12 | 8.0 | -25 | 1.5 | 18 | -29 | 0.1 | 0.7 | -17 | 16 | -20 | 25 | -32 | -28 | -53 | -35 | 31 | 43 | -97 | 0.6 | -26 | 18 | 6.2 | -23 | 35 | 64 | -38 | -26 | -6.9 | -45 | -23 | -59 | -11 | 36 | -12 | -37 | -23 | |
| 3.9 | 4.4 | 6.0 | 6.5 | 8.9 | 6.5 | 9.6 | 11 | 8.9 | 10 | 9.5 | 8.3 | 8.6 | 9.2 | 7.4 | 10 | 6.2 | 5.9 | 5.9 | 5.6 | 6.2 | 7.2 | 8.5 | 9.2 | 9.9 | 11 | 9.1 | 6.8 | 6.8 | 6.1 | 5.3 | 7.1 | 6.3 | 6.2 | 8.6 | 8.8 | 9.0 | 7.8 | 6.4 | 13 | 36 | |
| -4.4 | -75 | 4.6 | 3.1 | 9.3 | -33 | -13 | -6.7 | -5.6 | -135 | -25 | -65 | -12 | -79 | -11 | -7.6 | 282 | -2.2 | 46 | -5.6 | -1.8 | -54 | 17 | -16 | -255 | -4.5 | -395 | -8.4 | -409 | -6.1 | -9.7 | -14 | -20 | -20 | -13 | -61 | -8.8 | 82 | -6.4 | -13 | 54 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | 20 | – | 1.3 | 1.1 | 1.1 | 1.1 | 14 | 222 | 15 | 3.7 | 4.9 | 5.1 | 5.2 | 5.1 | 5.1 | 5.1 | 4.8 | 4.6 | 4.6 | 1.9 | 0.0 | 0.0 | 0.0 | 1.9 | |
| 0.0 | 0.0 | -0.7 | -0.5 | 0.0 | -0.1 | -0.8 | -0.3 | -0.1 | -0.1 | -2.2 | -0.2 | 0.0 | -0.2 | -1.2 | -0.1 | -0.1 | -0.5 | -2.7 | -0.5 | -0.3 | -0.5 | -16 | -0.3 | -0.9 | 1.2 | 170 | 3.1 | 164 | -0.9 | -14 | -0.4 | -0.7 | -0.3 | -4.6 | 0.0 | -40 | -51 | -1.8 | – | – | |
| 0.0 | 121 | -0.7 | -0.5 | 0.0 | -4.2 | -22 | 15 | -10 | 281 | -108 | -12 | 97 | -18 | 34 | 14 | -20 | -0.2 | -98 | -0.4 | -0.4 | -0.4 | 220 | 220 | 220 | -0.3 | 219 | -0.3 | -10 | – | – | – | 0.0 | 59 | 159 | 0.0 | 2.0 | -95 | 0.0 | -10 | -103 | |
| 1.1 | 121 | -0.1 | 2.5 | 167 | -4.0 | -22 | 18 | -4.3 | 282 | -110 | -11 | 97 | -11 | 33 | -6.7 | -14 | -24 | -56 | -36 | 0.6 | 61 | -51 | 21 | 173 | -11 | 380 | 23 | -37 | -84 | 15 | -103 | -9.0 | 97 | 108 | -8.9 | -42 | -93 | -4.0 | -15 | -154 | |
| 4.6 | 25 | -30 | -4.3 | 187 | 8.2 | -59 | 18 | 13 | 121 | -161 | -90 | 69 | -77 | 1.3 | 23 | 247 | -59 | -58 | -64 | 44 | 73 | -92 | 18 | -86 | 20 | -23 | 16 | 17 | -1.2 | 10 | -95 | -8.4 | 51 | 99 | -87 | -35 | 38 | -12 | -39 | -49 | |
| 4.1 | -26 | -41 | -16 | 1.8 | 3.4 | -34 | -4.0 | 13 | -35 | -35 | -22 | -25 | 4.0 | -28 | 28 | -27 | -19 | -54 | -30 | 38 | 59 | -66 | 4.4 | -13 | 25 | -17 | -6.2 | 54 | 83 | -0.4 | 14 | 12 | -32 | -4.0 | -39 | 6.9 | 41 | -7.4 | -24 | 17 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.